IVD News and Research

RSS

Candida Auris testing kit for use in hospital hygiene applications announced by Bruker

At the International Society for Human and Animal Mycology meeting, Bruker announces Fungiplex™ Candida Auris, a new research-use-only, real-time PCR assay and kit for the detection of Candida auris in hospital hygiene applications.

From Bruker Life Sciences Mass Spectrometry 4 Jul 2018

OGT announces direct sales and support services in Europe

Oxford Gene Technology, The Molecular Genetics Company, has announced that it is now directly selling Cytocell Fluorescence In Situ Hybridisation products through several established affiliates of SysmexCorporation in Europe following its acquisition last year.

From Oxford Gene Technology 4 Jul 2018

Molecular Health introduces MH Mendel to help geneticists in diagnosing hereditary diseases

Molecular Health, a leading biomedical company that is transforming molecular data into clinically actionable information for efficient and safer cancer treatment options based on its proprietary Dataome® technology platform, has introduced Molecular Health Guide® Mendel as part of the established Molecular Health Guide®, a comprehensive software solution for precision medicine.

13 Jun 2018

$FDA authorizes marketing of OsteoDetect software for detecting wrist fractures$

FDA authorizes marketing of OsteoDetect software for detecting wrist fractures

Today, the U.S. Food and Drug Administration permitted marketing of Imagen OsteoDetect, a type of computer-aided detection and diagnosis software designed to detect wrist fractures in adult patients.

25 May 2018

BD introduces new informatics and automation solutions for clinical laboratories

BD (Becton, Dickinson and Company), a leading global medical technology company, today introduced several new informatics and automation solutions for clinical laboratories, which may play a critical role in the fight against infectious diseases and antimicrobial resistance.

From BD (Becton, Dickinson and Company) 20 Apr 2018

TradeShow Talks with Cyanagen

We are Cyanagen, an Italian company, here at Analytica in hall A3 booth 416. We produce reagents for molecular biology, mainly ECL substrates for Western blot analyzers and fluorescent reagents for several applications.

From Cyanagen Srl 12 Apr 2018

Tradeshow Talks with POREX

News Medical talk to POREX to find out why they are exhibiting at analytica 2018.

From Porex Corporation 11 Apr 2018

Oxford Gene Technology announces leadership changes

Oxford Gene Technology, The Molecular Genetics Company, has announced that on 1st April 2018 Dr John Anson who has been with the company since 2006 as EVP of R&D took over as CEO from Dr Mike Evans, who has become a non-executive director of OGT’s board.

From Oxford Gene Technology 10 Apr 2018

Porex to display innovations in laboratory liquid handling, diagnostics and chromatography at Analytica 2018

At next month’s Analytica event, Porex Corporation will display new solutions for laboratory and medical professionals that improve accuracy and purity in liquid handling, speed fluid transfer of diagnostics and optimize chromatography operations.

From Porex Corporation 31 Mar 2018

FDA permits marketing of Dexcom G6 integrated continuous glucose monitoring system

The U.S. Food and Drug Administration today permitted marketing of the Dexcom G6 integrated continuous glucose monitoring system for determining blood glucose (sugar) levels in children aged two and older and adults with diabetes.

28 Mar 2018

Vitl Life Science Solutions announces launch of new Lu-mini at analytica 2018

Vitl Life Science Solutions, a member of the ITL Group, announce the highly-anticipated launch of the Lu-mini – a new product set to revolutionize the market for low-cost OEM benchtop luminometers.

19 Mar 2018

Technological advances in biosensors could reduce spread of HIV infection

1.8 million people acquire HIV each year, with the World Health Organisation estimating that 1 in 5 people living with HIV do not realize they are infected. Therefore, strategies for faster and earlier diagnosis are as important as ever to limit the spread of HIV.

From IDTechEx Ltd 7 Mar 2018

GlobalData reveals increasing demand for IVD testing as focus on personalized medicine becomes the norm

The in vitro diagnostic testing market is one of the fastest-growing segments within the medtech industry.

12 Feb 2018

Eagle Biosciences launches novel Intact FGF23 ELISA Assay Kit

Eagle Biosciences, Inc. is proud to announce the launch of a new assay, MedFrontier FGF23 (Human Intact FGF23) ELISA Assay Kit. This assay was developed and manufactured by Kyowa Medex Co., Ltd from Tokyo, Japan.

27 Jan 2018

Study tests accuracy of laboratory-developed cancer tests and FDA-approved companion diagnostics

Cancer molecular testing can drive clinical decision making and help a clinician determine if a patient is a good candidate for a targeted therapeutic drug.

14 Dec 2017

FDA grants clearance to new blood cell count test that allows faster availability of results

The U.S. Food and Drug Administration today cleared a complete blood cell count (CBC) test that, based on its categorization, can be run in more health care settings, including physicians' offices, clinics or other types of health care facilities, by a wider range of personnel (e.g. support staff). This broadened test access will allow for faster availability of results.

6 Nov 2017

Report sheds light on global market for infectious disease immunoassays

Kalorama Information says that infectious disease immunoassays beat the IVD market and the overall IVD market in terms of revenue growth. Immunoassays are tests that are based on the binding of antibodies to antigens to identify the presence of a substance.

16 Oct 2017

ITL Group returns to MEDICA 2017 to discuss future of diagnostic devices

Leading medical device design and manufacturing company, ITL Group returns to the MEDICA tradeshow in Düsseldorf, Germany this November with a simple message – ‘your future rests with us.’

From Vitl Life Science Solutions 6 Oct 2017

FDA approves FreeStyle Libre Flash Glucose Monitoring System for adult patients with diabetes

The U.S. Food and Drug Administration today approved the FreeStyle Libre Flash Glucose Monitoring System, the first continuous glucose monitoring system that can be used by adult patients to make diabetes treatment decisions without calibration using a blood sample from the fingertip.

27 Sep 2017

Simple blood test provides new treatment choices to lung cancer patients

A simple test which can detect gene mutations in tumour DNA from blood samples is giving new choices to lung cancer patients with faster diagnosis and improved access to life changing drugs.

15 Sep 2017